Anagram was interviewed (La Vanguardia 20 Feb 2019) and explained a little of the company’s vision and mission.
Most of our clients are small and medium-sized companies or startups, working on new drugs or medical devices. We can work with any size client, but our flexibility and adaptability to the sponsor’s needs make us the ideal partner for small and medium sized companies. We also work extensively with Key Opinion Leaders sponsoring their own PI promoted trials to help improve their patients’ treatment options.
Our strategy allows us to accompany our clients from very early phases and help them design and execute the best strategy for their drugs or devices. We focus on data quality, without forgetting the importance of timelines and budgets, to ensure new treatments are soon launched in the market.
Anagram became member of CataloniaBio & Health Tech. This association of companies represents the biomedicine and health arena in Catalonia. Its mission is to promote research, development and innovation to help the business fabric generate new products and services in biopharmaceuticals, medical technology and digital health to improve people’s wellbeing.